• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺眼病的眼眶临床病理差异:细胞因子与组织病理学及临床相关性分析

Orbital Clinicopathological Differences in Thyroid Eye Disease: An Analysis of Cytokines With Histopathological and Clinical Correlation.

作者信息

Li Yue, Tang Jiaqi, Jing Gaojing, Li Yueyue, Ma Rui, Kang Xin, Rong Liyuan, Liu Wenlu, Yao Lan, Lv Xiaohui, Deng Aijun, Wu Wei, Yang Xinji

机构信息

School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.

Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital, Beijing, China.

出版信息

Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):33. doi: 10.1167/iovs.66.3.33.

DOI:10.1167/iovs.66.3.33
PMID:40100205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11927299/
Abstract

PURPOSE

To explore the pathological differences in orbital adipose/connective tissue between active and inactive thyroid eye disease (TED) subjects and their correlations with clinical characteristics.

METHODS

Orbital adipose/connective tissue samples from 42 TED subjects (20 active, 22 inactive) were collected during decompression surgery. We analyzed cytokine expression, inflammatory cell infiltration, inherent cell populations, and interstitial changes by Luminex and histopathology. Correlations were analyzed using Pearson and Spearman correlation analyses.

RESULTS

Among the 108 cytokines detected, active TED exhibited elevated platelet endothelial cell adhesion molecule 1 (PECAM-1), interleukin-23 (IL-23), a proliferation-inducing ligand (APRIL), IL-6, C-C motif chemokine ligand 2 (CCL2), β-nerve growth factor (NGF), and lower CCL21 and CCL5. The extent of infiltration by helper T (Th) cells and monocytes was significantly greater in the active group than in the inactive group. Adipocyte density was significantly elevated in active TED, whereas fibrosis was more prominent in inactive TED. Fifteen cytokines were significantly associated with inflammatory cell infiltration, with IL-16 showing the strongest correlations with T cells. Ten cytokines showed significant positive correlations with fibrosis. Four cytokines (IL-6, PECAM-1, IL-23 and transforming growth factor β1), Th cell infiltration and adipocyte density were significantly positively correlated with clinical activity score (CAS). Sixteen cytokines, along with adipocyte density, were significantly positively correlated with disease severity of TED.

CONCLUSIONS

The orbital adipose/connective tissues of active and inactive TED subjects showed significant differences in terms of cytokines, inflammatory cells infiltration, inherent cells and interstitium. These pathological changes were correlated with clinical characteristics of TED.

摘要

目的

探讨活动期和非活动期甲状腺眼病(TED)患者眼眶脂肪/结缔组织的病理差异及其与临床特征的相关性。

方法

在减压手术期间收集42例TED患者(20例活动期,22例非活动期)的眼眶脂肪/结缔组织样本。我们通过Luminex和组织病理学分析细胞因子表达、炎性细胞浸润、固有细胞群和间质变化。使用Pearson和Spearman相关性分析来分析相关性。

结果

在检测的108种细胞因子中,活动期TED患者的血小板内皮细胞黏附分子1(PECAM-1)、白细胞介素-23(IL-23)、增殖诱导配体(APRIL)、IL-6、C-C基序趋化因子配体2(CCL2)、β-神经生长因子(NGF)升高,而CCL21和CCL5降低。活动期组辅助性T(Th)细胞和单核细胞的浸润程度明显高于非活动期组。活动期TED患者的脂肪细胞密度显著升高,而非活动期TED患者的纤维化更为明显。15种细胞因子与炎性细胞浸润显著相关,其中IL-16与T细胞的相关性最强。10种细胞因子与纤维化呈显著正相关。4种细胞因子(IL-6、PECAM-1、IL-23和转化生长因子β1)、Th细胞浸润和脂肪细胞密度与临床活动评分(CAS)显著正相关。16种细胞因子以及脂肪细胞密度与TED的疾病严重程度显著正相关。

结论

活动期和非活动期TED患者的眼眶脂肪/结缔组织在细胞因子、炎性细胞浸润、固有细胞和间质方面存在显著差异。这些病理变化与TED的临床特征相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/1ba89906c0c6/iovs-66-3-33-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/681645b05bd2/iovs-66-3-33-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/62563f0620bd/iovs-66-3-33-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/a0a46b67c405/iovs-66-3-33-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/b9dcd47a7681/iovs-66-3-33-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/1ba89906c0c6/iovs-66-3-33-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/681645b05bd2/iovs-66-3-33-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/62563f0620bd/iovs-66-3-33-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/a0a46b67c405/iovs-66-3-33-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/b9dcd47a7681/iovs-66-3-33-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/11927299/1ba89906c0c6/iovs-66-3-33-f005.jpg

相似文献

1
Orbital Clinicopathological Differences in Thyroid Eye Disease: An Analysis of Cytokines With Histopathological and Clinical Correlation.甲状腺眼病的眼眶临床病理差异:细胞因子与组织病理学及临床相关性分析
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):33. doi: 10.1167/iovs.66.3.33.
2
A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease.甲状腺眼病眼眶组织的多中心、单盲、病例对照、免疫组织化学研究。
Thyroid. 2022 Dec;32(12):1547-1558. doi: 10.1089/thy.2022.0173. Epub 2022 Oct 31.
3
Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids.大剂量静脉注射糖皮质激素治疗活动期甲状腺眼病患者的泪液炎症细胞因子和眼表变化。
J Endocrinol Invest. 2020 Jul;43(7):901-910. doi: 10.1007/s40618-019-01174-8. Epub 2020 Jan 11.
4
Potential role of IGF-1R in the interaction between orbital fibroblasts and B lymphocytes: an implication for B lymphocyte depletion in the active inflammatory phase of thyroid-associated ophthalmopathy.IGF-1R 在眼眶成纤维细胞和 B 淋巴细胞相互作用中的潜在作用:提示甲状腺相关眼病活动炎症期 B 淋巴细胞耗竭。
BMC Immunol. 2024 May 11;25(1):31. doi: 10.1186/s12865-024-00613-3.
5
Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation.甲状腺眼病中的眼眶血管生成和淋巴管生成:血管生长因子与临床相关性分析
Ophthalmology. 2016 Sep;123(9):2028-36. doi: 10.1016/j.ophtha.2016.05.052. Epub 2016 Jul 14.
6
LncRNA LPAL2/miR-1287-5p/EGFR Axis Modulates TED-Derived Orbital Fibroblast Activation Through Cell Adhesion Factors.长链非编码RNA LPAL2/微小RNA-1287-5p/表皮生长因子受体轴通过细胞黏附因子调节甲状腺相关眼病来源的眼眶成纤维细胞活化。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e2866-e2886. doi: 10.1210/clinem/dgab256.
7
Endoplasmic reticulum protein TXNDC5 modulates thyroid eye disease TGF-β1-induced myofibroblast transdifferentiation.内质网蛋白TXNDC5调节甲状腺眼病中转化生长因子-β1诱导的肌成纤维细胞转分化。
BMJ Open Ophthalmol. 2024 Dec 25;9(1):e001693. doi: 10.1136/bmjophth-2024-001693.
8
PAPP-A as a Potential Target in Thyroid Eye Disease.PAPP-A 作为甲状腺眼病的潜在靶点。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3119-3125. doi: 10.1210/clinem/dgae339.
9
Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.从眶内、鼻腔和中央脂肪组织培养的人眼眶成纤维细胞的特征。
Br J Ophthalmol. 2021 Feb;105(2):290-296. doi: 10.1136/bjophthalmol-2018-313699. Epub 2019 Sep 5.
10
Transcriptomic profiling of thyroid eye disease orbital fat demonstrates differences in adipogenicity and IGF-1R pathway.甲状腺眼病眼眶脂肪的转录组分析显示了脂肪生成和IGF-1R途径的差异。
JCI Insight. 2024 Dec 20;9(24):e182352. doi: 10.1172/jci.insight.182352.

引用本文的文献

1
Epac1 Inhibits Orbital Fibroblast Activation to Ameliorate Thyroid-Associated Orbitopathy-Like Features Through the JAK/STAT Signaling Pathway.Epac1通过JAK/STAT信号通路抑制眼眶成纤维细胞活化,以改善甲状腺相关眼病样特征。
Invest Ophthalmol Vis Sci. 2025 Jul 1;66(9):68. doi: 10.1167/iovs.66.9.68.

本文引用的文献

1
Inducible ablation alleviates cardiac fibrosis via regulation of microtubule stability.诱导性消融通过调节微管稳定性减轻心脏纤维化。
Acta Biochim Biophys Sin (Shanghai). 2024 May 30;56(12):1802-1812. doi: 10.3724/abbs.2024075.
2
Roles of four targets in the pathogenesis of graves' orbitopathy.四个靶点在格雷夫斯眼眶病发病机制中的作用。
Heliyon. 2023 Aug 29;9(9):e19250. doi: 10.1016/j.heliyon.2023.e19250. eCollection 2023 Sep.
3
M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor.
M1 样巨噬细胞调节格雷夫斯眼病眼眶成纤维细胞的纤维化和炎症:可溶性白细胞介素 6 受体的潜在相关性。
Thyroid. 2023 Mar;33(3):338-350. doi: 10.1089/thy.2022.0254. Epub 2023 Feb 20.
4
Cytokines in Thyroid-Associated Ophthalmopathy.甲状腺相关眼病中的细胞因子。
J Immunol Res. 2022 Nov 14;2022:2528046. doi: 10.1155/2022/2528046. eCollection 2022.
5
A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease.甲状腺眼病眼眶组织的多中心、单盲、病例对照、免疫组织化学研究。
Thyroid. 2022 Dec;32(12):1547-1558. doi: 10.1089/thy.2022.0173. Epub 2022 Oct 31.
6
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.2021 年欧洲 Graves 眼病专家组(EUGOGO)Graves 眼病医学管理临床实践指南。
Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479.
7
Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.Graves 眼病眼眶成纤维细胞蛋白质组学与 DNA 甲基化的综合分析
Front Endocrinol (Lausanne). 2021 Feb 15;11:619989. doi: 10.3389/fendo.2020.619989. eCollection 2020.
8
Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy.甲状腺相关性眼病中,升高的白细胞介素-38 抑制白细胞介素-23R 的表达和白细胞介素-17A 的产生。
Int Immunopharmacol. 2021 Feb;91:107300. doi: 10.1016/j.intimp.2020.107300. Epub 2020 Dec 28.
9
Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy.格雷夫斯眼病的流行病学、自然史、危险因素和预防。
Front Endocrinol (Lausanne). 2020 Nov 30;11:615993. doi: 10.3389/fendo.2020.615993. eCollection 2020.
10
Distinctive Features of Orbital Adipose Tissue (OAT) in Graves' Orbitopathy.格雷夫斯眼眶病中眼眶脂肪组织(OAT)的独特特征。
Int J Mol Sci. 2020 Nov 30;21(23):9145. doi: 10.3390/ijms21239145.